1 – 10 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/- T Acute Lymphoblastic Leukemia
(
- Contribution to journal › Article
- 2021
-
Mark
Towards homogenization of total body irradiation practices in pediatric patients across SIOPE affiliated centers. A survey by the SIOPE radiation oncology working group
(
- Contribution to journal › Article
-
Mark
Resolving the Cellular Heterogeneity of Human Hematopoietic Stem and Progenitor Cells. The influence of cellular heterogeneity on ontogeny, ageing and leukemia.
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Molecular and Functional Dynamics of Hematopoietic Progenitor Cell Fate During Ontogeny
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Role of FLT3 in Acute Myeloid Leukemia: Molecular mechanisms and Therapeutic opportunities
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Helical tomotherapy for total marrow and total skin irradiation : Optimisation, verification, and clinical results
2021) 1.(
- Thesis › Doctoral thesis (compilation)
- 2020
-
Mark
The importance of the setting during sedation for intrathecal chemotherapy in pediatric oncology care : A case study
(
- Contribution to journal › Article
- 2019
-
Mark
Multiparameter Flow Cytometry Applications in the Diagnosis of Mixed Phenotype Acute Leukemia
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Late mortality and morbidity among long-term leukemia survivors with Down syndrome : A nationwide population-based cohort study
(
- Contribution to journal › Article
- 2017
-
Mark
The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)
(
- Contribution to journal › Article